Paroxetine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Paroxetine and local guidelines before prescribing.
Mechanism
SSRI with anticholinergic activity.
Uses
Depression, OCD, panic and social anxiety, PTSD.
Dosing
- SSRIs - sertraline, citalopram, escitalopram, fluoxetine, paroxetine | Usual first choice - safer in overdose. Sertraline - preferred after MI or with heart disease. Citalopram/escitalopram - QT prolongation (citalopram max 20 mg over 65). Fluoxetine - long half-life (fewer withdrawal effects), many interactions; first-line in young …
Psychiatry: Mood disorders
Side effects
Nausea, sexual dysfunction, weight gain, anticholinergic effects, marked discontinuation symptoms, bleeding risk.
Interactions
Strong CYP2D6 inhibitor: tamoxifen (reduces activation), tricyclics, beta-blockers, flecainide; MAOIs.
Contraindications and cautions
Mania, uncontrolled epilepsy
Monitoring
Sodium, suicidality in young people
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in severe renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
Taper slowly; avoid in pregnancy (cardiac malformation); avoid with tamoxifen.
More from the textbook: uses, cautions and other points
- SSRIs or SNRIs - avoid paroxetine and fluoxetine with tamoxifen.
Endocrinology: Reproductive - Tamoxifen | VTE, endometrial cancer, hot flushes; avoid fluoxetine and paroxetine.
Oncology: Principles - Tamoxifen: VTE and endometrial cancer; avoid fluoxetine and paroxetine. Aromatase inhibitors: bone loss.
Oncology: Principles - SSRIs or SNRIs (venlafaxine, citalopram - avoid fluoxetine and paroxetine with tamoxifen ).
Oncology: Breast and Gynae Cancers - Tamoxifen | ER-positive breast cancer and prevention; VTE, endometrial cancer, hot flushes; avoid fluoxetine and paroxetine.
Oncology: Breast and Gynae Cancers - After breast cancer, avoid systemic HRT; use non-hormonal options; avoid fluoxetine and paroxetine with tamoxifen.
Oncology: Breast and Gynae Cancers - Mental health — sertraline and other SSRIs commonly continued (small risks — PPHN, neonatal adaptation); avoid paroxetine (cardiac) where possible; perinatal mental health team.
Obstetrics - SSRIs or SNRIs (e.g. venlafaxine, citalopram) - avoid fluoxetine and paroxetine with tamoxifen (they reduce its effect).
Gynaecology: Fertility Contraception Menopause
Where it is discussed in the book
- Endocrinology: Reproductive (1 mention)
- Oncology: Principles (3 mentions)
- Oncology: Breast and Gynae Cancers (3 mentions)
- Obstetrics (1 mention)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Psychiatry: Anxiety, stress and somatic disorders (4 mentions)
- Psychiatry: Mood disorders (5 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (2 mentions)